Key result
Percutaneous valve replacement and repair technologies rapidly advance as new devices approach Phase I trials.
This review summarizes the state of the art in percutaneous valve replacement and repair technologies.
Clinicians should track emerging percutaneous valve options; leaves open long-term efficacy and safety pending Phase I-III data.
Technical developments in valvular intervention culminated in the first percutaneous valve replacement in the pulmonary position (2000) followed by replacement in the aortic position (2002). More recently, with the proven feasibility of percutaneous mitral valve repair, interventional cardiologists and cardiothoracic surgeons have begun to develop a new subspecialty dedicated to the percutaneous treatment of valvular disease. This review describes the clinical status of the current field, the applicability and limitations of new technologies, and the upcoming devices that will soon reach Phase I clinical trials.
No takes yet. Share an insight, caveat, or question.
Babaliaros et al. (2006) conducted a review in Valvular Heart Disease. Percutaneous valve replacement and repair was evaluated. Percutaneous valve replacement and repair technologies are advancing rapidly, with new devices for valvular heart disease approaching Phase I clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: